Total 2, page 1/1
| No. | Organization | Therapeutic Area | Product Type | Title |
|---|---|---|---|---|
| 25 | FDA Technology Transfer | Oncology | Antibody | Chimeric Immunotoxins Targeting IL-13Rα2 Positive Human Cancers |
| 24 | FDA Technology Transfer | Oncology | Cell therapy | Chimeric Antigen Receptor (CAR)-T cells Targeting IL-13Rα2 Positive Human Solid Cancers |
